Literature DB >> 28752160

Saliva, Serum Levels of Interleukin-21, -33 and Prostaglandin E2 in Patients with Generalised Aggressive or Chronic Periodontitis.

Pınar Gümüş, Nejat Nizam, Ayşe Nalbantsoy, Özgün Özçaka, Nurcan Buduneli.   

Abstract

PURPOSE: This cross-sectional study aims to evaluate saliva, serum levels of interleukin-21 (IL-21), IL-33, and prostaglandin E2 (PGE2) in patients with generalised chronic periodontitis or aggressive periodontitis.
MATERIALS AND METHODS: Before initiation of any periodontal treatment, saliva and serum samples were collected and clinical periodontal measurements were recorded from 94 participants (25 aggressive periodontitis patients, 25 chronic periodontitis patients, 44 periodontally healthy individuals). IL-21, IL-33 and PGE2 levels in serum and saliva samples were determined by ELISA. Data were tested statistically using Kruskal-Wallis, Mann-Whitney U-, and Spearman-rho rank tests.
RESULTS: Saliva IL-33 levels were statistically significantly higher in the chronic than the aggressive group (p < 0.05). Serum IL-33, saliva and serum IL-21 and PGE2 levels were similar in the two periodontitis groups. Saliva IL-33 levels correlated with age in the chronic periodontitis group (p < 0.05). Statistically significant positive correlations were found between serum, saliva PGE2 levels and plaque index (p < 0.05). IL-33 and IL-21 levels in serum samples positively correlated in the periodontitis groups (p < 0.05).
CONCLUSION: IL-21 and PGE2 analysis did not exhibit discriminating data between generalised chronic and aggressive periodontitis, but the present findings support the role of these cytokines in periodontitis. Statistically significantly higher saliva IL-33 levels in the chronic periodontitis group warrant further research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28752160     DOI: 10.3290/j.ohpd.a38740

Source DB:  PubMed          Journal:  Oral Health Prev Dent        ISSN: 1602-1622            Impact factor:   1.256


  6 in total

1.  Novel interleukin-33 and its soluble ST2 receptor as potential serum biomarkers in parotid gland tumors.

Authors:  Pawel Sowa; Maciej Misiolek; Maciej Zielinski; Bogdan Mazur; Monika Adamczyk-Sowa
Journal:  Exp Biol Med (Maywood)       Date:  2018-05

2.  Comparison of interleukin-21 levels and its correlation with clinical parameters among healthy individuals, chronic periodontitis, and aggressive periodontitis patients.

Authors:  Archana Mootha; Sankari Malaiappan; Dan M J Milstein; Gurumoorthy Karthikeyan; Sheeja S Varghese; N Doraisamy Jayakumar
Journal:  J Clin Transl Res       Date:  2021-02-02

3.  Association between the IL-10 rs1800872 polymorphisms and periodontitis susceptibility: A meta-analysis.

Authors:  Zao Wang; Yafang Li; Yanheng Zhou; Yiqiang Qiao
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.889

4.  Filifactor alocis and Tumor Necrosis Factor-Alpha Stimulate Synthesis of Visfatin by Human Macrophages.

Authors:  Andressa Vilas Boas Nogueira; Marjan Nokhbehsaim; Anna Damanaki; Sigrun Eick; Christian Kirschneck; Agnes Schröder; Jonathan Jantsch; James Deschner
Journal:  Int J Mol Sci       Date:  2021-01-27       Impact factor: 5.923

5.  Higher interleukin-33 levels in aggressive periodontitis cases.

Authors:  Sujatha Pai Ballambettu; A R Pradeep; Meera Purushottam; Somdatta Sen
Journal:  J Indian Soc Periodontol       Date:  2019 Sep-Oct

6.  Regulation of Cyclooxygenase 2 by Filifactor alocis in Fibroblastic and Monocytic Cells.

Authors:  Marjan Nokhbehsaim; Andressa V B Nogueira; Sandor Nietzsche; Sigrun Eick; James Deschner
Journal:  Mediators Inflamm       Date:  2020-02-03       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.